ArticleTransplant immunology2015

Pre-treatment of allogeneic bone marrow recipients with the CXCR4 antagonist AMD3100 transiently enhances hematopoietic chimerism without promoting donor-specific skin allograft tolerance.

Zhanzhuo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.